(Q33226124)

English

GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 July 2017

0 references

1 reference

Europe PubMed Central

GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

24 July 2017

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

Devroey P

1 reference

Europe PubMed Central

24 July 2017

author name string

Griesinger G

1

1 reference

Europe PubMed Central

24 July 2017

Diedrich K

2

1 reference

Europe PubMed Central

24 July 2017

Kolibianakis EM

4

1 reference

Europe PubMed Central

24 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

27 October 2005

1 reference

Europe PubMed Central

24 July 2017

Human Reproduction Update

1 reference

Europe PubMed Central

24 July 2017

12

1 reference

Europe PubMed Central

24 July 2017

2

1 reference

Europe PubMed Central

24 July 2017

159-168

1 reference

Europe PubMed Central

24 July 2017

Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertil

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

Induction of the endogenous gonadotrophin surge for oocyte maturation with intra-nasal gonadotrophin-releasing hormone analogue (buserelin): effective minimal dose

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

Severe OHSS: yes, there is a strategy to prevent it!

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

Ovarian hyperstimulation: effects of GnRH analogues. Ovarian hyperstimulation syndrome after using gonadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

Successful treatment of empty follicle syndrome by triggering endogenous LH surge using GnRH agonist in an antagonist down-regulated IVF cycle.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

Can we eliminate severe ovarian hyperstimulation syndrome?

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

Luteal phase support in infertility treatment: a meta-analysis of the randomized trials

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI045

21 January 2018

Identifiers

10.1093/HUMUPD/DMI045

1 reference

Europe PubMed Central

24 July 2017

1 reference

Europe PubMed Central

24 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33226124&oldid=1606613333"